Image of Jon Edwards

Jon Edwards

Associate

Email

jon.edwards@aoshearman.com

Phone

+44 20 3088 3367

Offices

London

V-CARD
Jon advises on intellectual property disputes and specialises in patent litigation.

He has experience advising a range of international clients across different sectors, predominantly in the Life Sciences and in Tech & Comms. Jon is particularly focused on pharmaceuticals, healthcare and MedTech after studying Pharmacology at undergraduate level and then working in the pharmaceutical industry after graduating.

Jon has experience providing IP enforcement advice to patent holders, as well as patent clearance and freedom-to-operate opinions to third parties. This experience equips Jon with a balanced perspective when providing strategic advice to clients.

Experience

Pro bono

Jon acts as a mentor for post-graduate IP students at Queen Mary, University of London. He has also previously volunteered at the South Westminster Legal Advice Clinic providing pro bono advice.

Published Work

  • Contributor to Sally Shorthouse (ed.), Bird & Bird LLP [2023] “EU and UK Pharmaceutical Regulatory Law”, London: Wolters Kluwer

Leadership Positions And Professional Affiliations

Jon is a member of the Society for Junior Intellectual Property Practitioners (IPSoc), and the International Association for the Protection of Intellectual Property (AIPPI)

Qualifications

Admissions

Admitted as a Solicitor (England and Wales), 2020

Academic

PgDip, Intellectual Property Law and Practice, Oxford University, 2022

Legal Practice Certificate, BPP University Holborn, 2018

Graduate Diploma in Law, University of Law Bloomsbury, 2016

MSc, Management of Intellectual Property, Queen Mary University of London, 2013

BSc, Pharmacology, University of Manchester, 2012

Languages

Italian
Disclaimer
A&O Shearman was formed on May 1, 2024 by the combination of Shearman & Sterling LLP and Allen & Overy LLP and their respective affiliates (the legacy firms). Any matters referred to above may include matters undertaken by one or more of the legacy firms rather than A&O Shearman.